beta-lactams has been researched along with thiazolyl blue in 2 studies
Studies (beta-lactams) | Trials (beta-lactams) | Recent Studies (post-2010) (beta-lactams) | Studies (thiazolyl blue) | Trials (thiazolyl blue) | Recent Studies (post-2010) (thiazolyl blue) |
---|---|---|---|---|---|
7,579 | 179 | 3,395 | 4,625 | 20 | 1,230 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ghosh, C; Haldar, J; Konai, MM; Samaddar, S; Yarlagadda, V | 1 |
Caboni, L; Carr, M; Knox, AJ; Meegan, MJ; Nathwani, SM; O'Boyle, NM; Pollock, JK; Wang, S; Zisterer, DM | 1 |
2 other study(ies) available for beta-lactams and thiazolyl blue
Article | Year |
---|---|
Membrane active phenylalanine conjugated lipophilic norspermidine derivatives with selective antibacterial activity.
Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Drug Design; Drug Resistance, Bacterial; Enterococcus faecium; Humans; Kinetics; Klebsiella pneumoniae; Methicillin-Resistant Staphylococcus aureus; Micelles; Microbial Sensitivity Tests; Molecular Conformation; Phenylalanine; Plasma; Serum; Spermidine; Tetrazolium Salts; Thiazoles; Vancomycin | 2014 |
β-Lactam estrogen receptor antagonists and a dual-targeting estrogen receptor/tubulin ligand.
Topics: Apoptosis; beta-Lactams; Cell Division; Chemistry, Pharmaceutical; Computer Simulation; Estrogen Receptor alpha; Estrogen Receptor Antagonists; Estrogen Receptor beta; Estrogens; G2 Phase; Humans; Inhibitory Concentration 50; L-Lactate Dehydrogenase; Ligands; MCF-7 Cells; Models, Molecular; Myeloid Cell Leukemia Sequence 1 Protein; Protein Binding; Proto-Oncogene Proteins c-bcl-2; Software; Tetrazolium Salts; Thiazoles; Tubulin | 2014 |